NEW HAVEN, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that the Company will issue a press release on its restructuring to advance its corporate strategy on Tuesday, September 12, 2017 at 8:00 a.m. ET. Following the release, Alexion management will conduct a conference call and audio webcast on Tuesday, September 12, 2017 at 8:30 a.m. ET.
To participate in this conference call, dial 800-406-5345 (USA) or 719-325-4744 (International), passcode 9877152 shortly before 8:30 a.m. ET. A replay of the call will be available from 1:00 p.m. ET through a limited time thereafter. The replay number is 888-203-1112 (USA) or 719-457-0820 (International), passcode 9877152. The audio webcast can be accessed on the Investor page of http://ir.alexion.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170911006144/en/
Elena Ridloff, CFA
Vice President, Investor Relations
Director, Investor Relations
Source: Alexion Pharmaceuticals
News Provided by Acquire Media